Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Autologous CD1c (BDCA-1)+ myDC |
Trade Name | |
Synonyms | |
Drug Descriptions |
Autologous CD1c (BDCA-1)+ MyDC are patient-derived myeloid dendritic cells expressing CD1c (BDCA-1), which potentially enhance antitumor immune response and inhibit tumor growth (PMID: 38212127). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Autologous CD1c (BDCA-1)+ myDC | Autologous CD1c (BDCA-1)+ myDC | 0 | 0 |
Autologous CD1c (BDCA-1)+ myDC + Ipilimumab + Nivolumab | Autologous CD1c (BDCA-1)+ myDC Ipilimumab Nivolumab | 0 | 1 |